10-K/A

Israel Acquisitions Corp (ISRLF)

10-K/A 2025-06-23 For: 2024-12-31
View Original
Added on April 06, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K/A

(Amendment No. 1)

(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended: December 31,2024

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________________to ____________________________________

Commission File Number: 001-41593

ISRAEL ACQUISITIONS CORP

(Exact name of registration as specified in its charter)

Cayman Islands 87-3587394
(State or other jurisdiction ofincorporation or organization) (I.R.S. EmployerIdentification No.)
12600 Hill Country Blvd, Building R, Suite 275
--- ---
Bee Cave, Texas 78738
(Address of principal executive offices) (Zip Code)
(800) 508-1531
---
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class TradingSymbol(s) Name of each exchange onwhich registered
Units, each consisting of one Class A ordinary share and one redeemable warrant ISRLU The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share ISRL The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share ISRLW The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) ofthe Act: NONE

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ¨ No  x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes  ¨ No  x

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (17 CFR §232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer x Smaller reporting company x
Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ¨

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  ¨

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).  ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes x No ¨

The aggregate market value of the ordinary shares

held by non-affiliates of the registrant, computed as of June 28, 2024 (the last business day of the registrant’s most recently completed second fiscal quarter), was $79,855,765 (based on the $11.00 closing sale price of the Registrant’s Class A ordinary shares on such date).

As of March 31, 2025, there were 1,560,432

Class A ordinary shares, par value $0.0001 per share issued and outstanding.

Documents incorporated by reference:

The Annual Report on Form 10-K filed by Israel Acquisitions Corp, filed with the United States Securities and Exchange Commission on March 31, 2025, is hereby incorporated by reference in its entirety (including into Parts I, II, and III).

Auditor Firm ID Auditor Name Auditor Location
243 BDO USA, P.C New York

EXPLANATORY NOTE

Israel Acquisitions Corp (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) for the year ended December 31, 2024, to amend the Company’s Annual Report on Form 10-K, originally filed with the United States Securities and Exchange Commission on March 31, 2025 (the “Original 10-K”), and the Original 10-K is incorporated by reference herein. The Original Form 10-K omitted Exhibit 97.1, which is the Company’s Clawback Policy. The Company is filing this Amendment No. 1 solely to include the omitted exhibit.

Pursuant to the rules of the SEC, Part IV, Item 15 (Exhibit Index) has also been amended to contain the currently dated certifications from our principal executive officer and principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. The certifications of our principal executive officer and principal financial officer are attached to this Amendment No. 1 as Exhibits 31.1 and 31.2, respectively. Because no financial statements have been included in this Amendment No. 1 and this Amendment No. 1 does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, we have omitted paragraphs 3, 4 and 5 of the certifications filed with this Amendment No. 1. Additionally, we are not including the certifications under Section 906 of the Sarbanes-Oxley Act of 2002, because we are not filing any financial statements with this Amendment No. 1.

This Amendment No. 1 speaks as of the original filing date of the Original Form 10-K. No other information included in the Original Form 10-K has been modified or updated in any way. The Original Form 10-K continues to speak as of the date of the original filing, and the Company has not updated the disclosures contained therein to reflect any events that occurred after the original filing other than as expressly indicated in this Amendment No. 1. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Form 10-K and the Company’s other SEC filings.

Item 15. Exhibits, Financial Statement Schedules.

(a)(3) Exhibits:

The exhibits listed on the Exhibit Index (following the signatures section of this report) are included, or incorporated by reference, in this annual report.

(b) Exhibits:

See Item 15(a)(3) above.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: June 23, 2025

ISRAEL ACQUISITIONS CORP
By: /s/ Ziv Elul
Name: Ziv Elul
Title: Chief Executive Officer and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Name Position Date
By: /s/ Ziv Elul Chief Executive Officer and Director June 23, 2025
Ziv Elul (Principal Executive Officer)
By: /s/ Sharon Barzik Cohen Chief Financial Officer and Director June 23, 2025
Sharon Barzik Cohen (Principal Financial and Accounting Officer)
By: /s/ Izhar Shay Director (Chairman) June 23, 2025
Izhar Shay
By: /s/ Candice Beaumont Director June 23, 2025
Candice Beaumont
By: /s/ Peter Cohen Director June 23, 2025
Peter Cohen
By: /s/ Roy Zisapel Director June 23, 2025
Roy Zisapel
By: /s/ Daniel Recanati Director June 23, 2025
Daniel Recanati

EXHIBIT INDEX

Incorporated by Reference
Exhibit<br><br>No. Exhibit Description Form SEC File <br><br>No. Exhibit Filing<br><br>Date
1.1 Underwriting Agreement, dated January 12, 2023, by and among the Company and BTIG, LLC, as representative of the several underwriters. 8-K 001-41593 1.1 January 19, 2023
2.1 Business Combination Agreement, dated as of January 2, 2024, by and between the Company and Pomvom Ltd. 8-K 001-41593 2.1 January 2, 2024
2.2 Amendment No. 1 to the Business Combination Agreement, dated April 22, 2024, by and between Israel Acquisitions Corp and Pomvom Ltd. 8-K 001-41593 2.2 April 24, 2024
2.3 Business Combination Agreement, dated as of January 26, 2025, by and among, Israel Acquisitions Corp and Gadfin Ltd. 8-K 001-41593 2.1 January 27, 2025
3.1 Third Amended and Restated Memorandum and Articles of Association, dated January 8, 2024 8-K 001-41593 3.1 January 11, 2024
3.2 Fourth Amended and Restated Memorandum and Articles of Association, adopted on January 6, 2025. 8-K 001-41593 3.1 January 10, 2025
4.1 Specimen Unit Certificate S-1 333-263658 4.1 August 31, 2022
4.2 Specimen Class A Ordinary Share Certificate S-1 333-263658 4.2 August 31, 2022
4.3 Specimen Warrant Certificate (included in Exhibit 4.4) S-1 333-263658 4.4 August 31, 2022
4.4 Warrant Agreement, dated January 12, 2023, by and between the Company and American Stock Transfer & Trust Company, as warrant agent. 8-K 001-41593 4.1 January 19, 2023
4.5 Description of Securities 10-K 001-41593 4.5 April 17, 2023
10.1 Letter Agreement, dated January 12, 2023, by and among the Company, its executive officers, its directors and Israel Acquisitions Sponsor LLC. 8-K 001-41593 10.1 January 19, 2023
10.2 Investment Management Trust Agreement, dated January 12, 2023, by and between the Company and American Stock Transfer & Trust Company, as trustee. 8-K 001-41593 10.2 January 19, 2023
10.3 Registration Rights Agreement, dated January 12, 2023, by and among the Company, Israel Acquisitions Sponsor LLC, BTIG, LLC, Exos Capital LLC and JonesTrading Institutional Services LLC. 8-K 001-41593 10.3 January 19, 2023
10.4 Private Placement Units Purchase Agreement, dated January 12, 2023, by and between the Company and Israel Acquisitions Sponsor LLC. 8-K 001-41593 10.4 January 19, 2023
10.5 Private Placement Units Purchase Agreement, dated January 12, 2023, by and between the Company and BTIG, LLC. 8-K 001-41593 10.5 January 19, 2023
10.6 Private Placement Units Purchase Agreement, dated January 12, 2023, by and between the Company and Exos Capital LLC. 8-K 001-41593 10.6 January 19, 2023
--- --- --- --- --- ---
10.7 Private Placement Units Purchase Agreement, dated January 12, 2023, by and between the Company and JonesTrading Institutional Services LLC. 8-K 001-41593 10.7 January 19, 2023
10.8 Administrative Services Agreement, dated January 12, 2023, by and between the Company and Israel Acquisitions Sponsor LLC. 8-K 001-41593 10.8 January 19, 2023
10.9 Form of Indemnity Agreement S-1 333-263658 10.5 August 31, 2022
10.10 Promissory Note, dated January 26, 2022, issued to the Sponsor. S-1 333-263658 10.7 March 17, 2022
10.11 Securities Subscription Agreement, dated January 26, 2022, between the Company and Israel Acquisitions Sponsor LLC. S-1 333-263658 10.8 March 17, 2022
10.12 Sponsor Support Agreement, dated January 2, 2024, by and among the Company, Pomvom Ltd. and Israel Acquisitions Sponsor LLC. 8-K 001-41593 10.1 January 2, 2024
10.13 Form of Transaction Support Agreement. 8-K 001-41593 10.2 January 2, 2024
10.14 Form of Registration Rights and Lock-Up Agreement. 8-K 001-41593 10.3 January 2, 2024
10.15 Amendment to the Investment Management Trust Agreement, dated January 8, 2024, by and between Israel Acquisitions Corp and Equiniti Trust Company, LLC. 8-K 001-41593 10.1 January 11, 2024
10.16 Amended and Restated Sponsor Support Agreement, dated April 19, 2024, by and among the Company, Pomvom Ltd. and Israel Acquisitions Sponsor LLC. 10-Q 001-41593 10.1 May 15, 2024
10.17 Promissory Note, dated January 18, 2024, by and between the Company and Israel Acquisitions Sponsor. 10-Q 001-41593 10.5 May 15, 2024
10.18 Promissory Note, dated July 17, 2024, between the Company and Israel Acquisitions Sponsor LLC. 10-Q 001-41593 10.1 August 14, 2024
10.19 Amendment to the Investment Management Trust Agreement, dated January 6, 2025, by and between Israel Acquisitions Corp and Equiniti Trust Company, LLC. 8-K 001-41593 10.1 January 10, 2025
10.20 Promissory Note dated January 17, 2025, by and between the Company and the Sponsor 8-K 001-41593 10.1 January 22, 2025
10.21 Form of Sponsor Support Agreement. 8-K 001-41593 10.1 January 27, 2025
10.22 Form of Transaction Support Agreement. 8-K 001-41593 10.2 January 27, 2025
97.1* Clawback Policy
31.1 Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Security Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 10-K 001-41593 31.1 March 31, 2025
31.2 Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Security Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 10-K 001-41593 31.2 March 31, 2025
31.3* Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Security Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.4* Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Security Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 Certification of Chief Executive Officer pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
--- ---
32.2 Certification of Chief Financial Officer pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS* XBRL Instance Document
101.SCH* XBRL Taxonomy Extension Schema Document
101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF* XBRL Taxonomy Extension Definition Linkbase Document
101.LAB* XBRL Taxonomy Extension Labels Linkbase Document
101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File. Formatted in Inline XBRL and contained in exhibit 101.

*Filed herewith

** These certifications are being furnished solely to accompany this annual report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Exhibit 31.3

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIESEXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THESARBANES-OXLEY ACT OF 2002

I, Ziv Elul, certify that:

1. I have reviewed this Amendment No. 1 to the annual report on Form 10-K of Israel Acquisitions Corp;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary<br>to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period<br>covered by this report;
--- ---
Date: June 23, 2025
--- ---
/s/ Ziv Elul
---
Ziv Elul
Chief Executive Officer
(Principal Executive Officer)

Exhibit 31.4

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIESEXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THESARBANES-OXLEY ACT OF 2002

I, Sharon Barzik Cohen, certify that:

1. I have reviewed this Amendment No. 1 to the annual report on Form 10-K of Israel Acquisitions Corp;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary<br>to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period<br>covered by this report;
--- ---
Date: June 23, 2025
--- ---
/s/ Sharon Barzik Cohen
---
Sharon Barzik Cohen
Chief Financial Officer
(Principal Financial and Accounting Officer)

Exhibit 97.1

ISRAEL ACQUISITIONS CORP

CLAWBACK POLICY

Introduction

The Board of Directors (the “Board”) of Israel Acquisitions Corp (the “Company”) believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosophy. The Board has therefore adopted this policy which provides for the recoupment of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the federal securities laws (the “Policy”). This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934 (the “Exchange Act”) and Nasdaq Listing Rule 5608 (the “ClawbackListing Standards”).

Administration

This Policy shall be administered by the Board or, if so designated by the Board, the compensation committee of the Board (the “Compensation Committee”), in which case references herein to the Board shall be deemed references to the Compensation Committee. Any determinations made by the Board shall be final and binding on all affected individuals.

Covered Executives

This Policy applies to the Company’s current and former executive officers, as determined by the Board in accordance with the definition in Section 10D of the Exchange Act and the Clawback Listing Standards, and such other senior executives who may from time to time be deemed subject to the Policy by the Board (“Covered Executives”).

Recoupment; Accounting Restatement

In the event the Company is required to prepare an accounting restatement of its financial statements due to the Company’s material noncompliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, the Board will require reimbursement or forfeiture of any excess Incentive Compensation received by any Covered Executive during the three completed fiscal years immediately preceding the date on which the Company is required to prepare an accounting restatement.

Incentive Compensation

For purposes of this Policy, “Incentive Compensation” means any of the following; provided that, such compensation is granted, earned, or vested based wholly or in part on the attainment of a financial reporting measure:

· Annual bonuses and other short- and long-term cash incentives.
· Stock options.
· Stock appreciation rights.
· Restricted stock.
--- ---
· Restricted stock units.
· Performance shares.
· Performance units.

Financial reporting measures include:

· Company stock price.
· Total shareholder return.
· Revenues.
· Net income.
· Earnings before interest, taxes, depreciation, and amortization (EBITDA).
· Funds from operations.
· Liquidity measures such as working capital or operating cash flow.
· Return measures such as return on invested capital or return on assets.
· Earnings measures such as earnings per share.

Excess Incentive Compensation: Amount Subject to Recovery

The amount to be recovered will be the excess of the Incentive Compensation paid to the Covered Executive based on the erroneous data over the Incentive Compensation that would have been paid to the Covered Executive had it been based on the restated results, as determined by the Board, without regard to any taxes paid by the Covered Executive in respect of the Incentive Compensation paid based on the erroneous data.

If the Board cannot determine the amount of excess Incentive Compensation received by the Covered Executive directly from the information in the accounting restatement, then it will make its determination based on a reasonable estimate of the effect of the accounting restatement.

Method of Recoupment

The Board will determine, in its sole discretion, the method for recouping Incentive Compensation hereunder which may include, without limitation:

(a) requiring reimbursement of cash Incentive Compensation previously paid;

(b) seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based awards;

(c) offsetting the recouped amount from any compensation otherwise owed by the Company to the Covered Executive;

(d) cancelling outstanding vested or unvested equity awards; and/or

(e) taking any other remedial and recovery action permitted by law, as determined by the Board.

2

No Indemnification

The Company shall not indemnify any Covered Executives against the loss of any incorrectly awarded Incentive Compensation.

Interpretation

The Board is authorized to interpret and construe this Policy and to make all determinations necessary, appropriate, or advisable for the administration of this Policy. It is intended that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Exchange Act, any applicable rules or standards adopted by the Securities and Exchange Commission, and the Clawback Listing Standards.

Effective Date

This Policy shall be effective as of the date it is adopted by the Board (the “Effective Date”) and shall apply to Incentive Compensation that is received by Covered Executives on or after the Effective Date, even if such Incentive Compensation was approved, awarded, or granted to Covered Executives prior to the Effective Date.

Amendment; Termination

The Board may amend this Policy from time to time in its discretion and shall amend this Policy as it deems necessary to reflect final regulations adopted by the Securities and Exchange Commission under Section 10D of the Exchange Act and to comply with the Clawback Listing Standards and any other rules or standards adopted by a national securities exchange on which the Company’s securities are listed. The Board may terminate this Policy at any time.

Other Recoupment Rights

Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights of recoupment that may be available to the Company pursuant to the terms of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies available to the Company.

Relationship to Other Plans and Agreements

The Board intends that this Policy will be applied to the fullest extent of the law. The Board may require that any employment agreement, equity award agreement, or similar agreement entered into on or after the Effective Date shall, as a condition to the grant of any benefit thereunder, require a Covered Executive to agree to abide by the terms of this Policy. In the event of any inconsistency between the terms of the Policy and the terms of any employment agreement, equity award agreement, or similar agreement under which Incentive Compensation has been granted, awarded, earned or paid to a Covered Executive, whether or not deferred, the terms of the Policy shall govern.

Acknowledgment

The Covered Executive shall sign an acknowledgment form in the form attached hereto as Exhibit A in which they acknowledge that they have read and understand the terms of the Policy and are bound by the Policy.

Impracticability

The Board shall recover any excess Incentive Compensation in accordance with this Policy unless such recovery would be impracticable, as determined by the Board in accordance with Rule 10D-1 of the Exchange Act and the listing standards of the national securities exchange on which the Company’s securities are listed.

Successors

This Policy shall be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators or other legal representatives.

3

Exhibit A

CLAWBACK POLICY ACKNOWLEDGMENT

The compensation committee (the “Compensation Committee”) of Israel Acquisitions Corp (the “Company”) has adopted a clawback policy ("Clawback Policy") which is applicable to the Company's Covered Executives (as defined in the Clawback Policy).

I, the undersigned, acknowledge that I have received a copy of the Clawback Policy, as it may be amended, restated, supplemented or modified from time to time, and that I have read it, understand it, and acknowledge that I am fully bound by, and subject to, all of the terms and conditions thereof.

In the event of any inconsistency between the terms of the Clawback Policy and the terms of any employment agreement to which I am a party, or the terms of any compensation plan, program, or arrangement under which Incentive Compensation (as defined in the Clawback Policy) has been granted, awarded, earned, or paid to me, whether or not deferred, the terms of the Clawback Policy shall govern.

If the Compensation Committee determines that any Incentive Compensation I have received must be forfeited, repaid, or otherwise recovered by the Company, I shall promptly take whatever action is necessary to effectuate such forfeiture, repayment, or recovery.

I acknowledge that I am not entitled to indemnification in connection with the Company's enforcement of the Clawback Policy.

I understand that any delay or failure by the Company to enforce any requirement contained in the Clawback Policy will not constitute a waiver of the Company's right to do so in the future.

Any capitalized terms used in this Acknowledgment that are not otherwise defined shall have the meaning ascribed to them in the Clawback Policy.

_______________________<br><br> <br>(Executive's Signature)<br><br> <br><br><br> <br>_______________________<br><br> <br>(Executive's Printed Name)<br><br> <br><br><br> <br>_______________________<br><br> <br>(Date)